HOLX,AZTA,RGEN Stock Price and Quote

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change +0.57
Percentage change 1.01	%

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB SPY VO IVV RSP VBR XLV SPLV

Index	S&P 500	P/E	23.96	EPS (ttm)	2.37	Insider Own	0.90%	Shs Outstand	222.84M	Perf Week	4.78%
Market Cap	12.65B	Forward P/E	12.53	EPS next Y	4.53	Insider Trans	-0.96%	Shs Float	220.84M	Perf Month	-4.32%
Income	556.70M	PEG	3.46	EPS next Q	1.06	Inst Own	103.45%	Short Float	3.04%	Perf Quarter	-12.12%
Sales	4.03B	P/S	3.14	EPS this Y	2.90%	Inst Trans	-1.96%	Short Ratio	2.19	Perf Half Y	-27.98%
Book/sh	20.73	P/B	2.74	EPS next Y	7.88%	ROA	6.45%	Short Interest	6.71M	Perf Year	-25.43%
Cash/sh	7.27	P/C	7.80	EPS next 5Y	6.92%	ROE	11.77%	52W Range	51.90 - 84.67	Perf YTD	-21.28%
Dividend Est.	-	P/FCF	12.70	EPS past 5Y	-	ROI	7.85%	52W High	-32.98%	Beta	0.54
Dividend TTM	-	Quick Ratio	2.52	Sales past 5Y	6.10%	Gross Margin	55.98%	52W Low	9.34%	ATR (14)	1.85
Dividend Ex-Date	-	Current Ratio	3.24	EPS Y/Y TTM	21.95%	Oper. Margin	23.72%	RSI (14)	46.39	Volatility	3.73% 2.90%
Employees	7063	Debt/Eq	0.55	Sales Y/Y TTM	1.66%	Profit Margin	13.83%	Recom	2.46	Target Price	68.20
Option/Short	Yes / Yes	LT Debt/Eq	0.54	EPS Q/Q	-110.78%	Payout	0.00%	Rel Volume	1.06	Prev Close	56.18
Sales Surprise	0.48%	EPS Surprise	1.37%	Sales Q/Q	-1.23%	Earnings	May 01 AMC	Avg Volume	3.07M	Price	56.75
SMA20	-0.31%	SMA50	-4.95%	SMA200	-21.68%	Trades		Volume	3,250,624	Change	1.01%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75
Jul-20-22	Initiated	UBS	Neutral	$73
Jul-20-22	Downgrade	BofA Securities	Buy → Neutral	$81 → $75
Jul-18-22	Downgrade	BTIG Research	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$75
Apr-04-22	Downgrade	Evercore ISI	Outperform → In-line	$80
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$85 → $78
Oct-15-21	Resumed	Cowen	Outperform	$83
Oct-14-21	Initiated	Redburn	Neutral

Show Previous Ratings

May-07-25 12:16PM	S&P 500's five most overbought and oversold stocks (Seeking Alpha)
May-06-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
12:32AM	1 of Wall Street's Favorite Stock with Impressive Fundamentals and 2 to Think Twice About (StockStory)
May-02-25 02:25PM	Analyst Report: Hologic, Inc. (Morningstar Research) -5.45%
11:57AM	Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More (Investopedia)
10:11AM	Loading…
10:11AM	Q2 2025 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
07:25AM	Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down (Zacks)
03:15AM	Hologic Inc (HOLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth (GuruFocus.com)
May-01-25 08:24PM	Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:10PM	Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:17PM	Hologic: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Second Quarter of Fiscal 2025 (Business Wire)
Apr-30-25 05:50PM	Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
09:31AM	Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss? (Zacks)
09:15AM	Loading…
Apr-28-25 09:15AM	Insights Into Hologic (HOLX) Q2: Wall Street Projections for Key Metrics (Zacks)
08:45AM	GYN Surgical Division Likely to Drive Hologic's Q2 Earnings (Zacks)
Apr-25-25 08:18AM	Hologic Set to Report Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Apr-24-25 08:10AM	Groundbreaking New Data on Hologics AI-Powered Mammography Technology to Be Presented at SBI (Business Wire)
Apr-23-25 09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Apr-22-25 10:10AM	Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside? (Zacks)
09:03AM	3 Cash-Producing Stocks Walking a Fine Line (StockStory)
08:08AM	Hologic Details Environmental, Social and Governance Efforts Including Expanded Environmental Ambitions in New Sustainability Report (Business Wire)
Apr-21-25 05:45PM	Hologic (HOLX) Stock Moves -1.08%: What You Should Know (Zacks)
Apr-14-25 05:45PM	Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
Apr-11-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-10-25 05:14AM	Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)
Apr-07-25 05:45PM	Hologic (HOLX) Advances While Market Declines: Some Information for Investors (Zacks)
08:48AM	Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? (Zacks)
Apr-04-25 04:15PM	Wayde McMillan Elected to Hologic Board of Directors (Business Wire)
04:30PM	Loading…
Apr-03-25 04:30PM	Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025 (Business Wire)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Mar-31-25 05:45PM	Hologic (HOLX) Outperforms Broader Market: What You Need to Know (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-24-25 05:45PM	Hologic (HOLX) Advances But Underperforms Market: Key Facts (Zacks)
Mar-20-25 11:46AM	New Product Launches to Support HOLX Stock Amid Macro Issues (Zacks)
Mar-19-25 09:57AM	HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip? (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Mar-17-25 05:45PM	Hologic (HOLX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Mar-13-25 06:58PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Mar-10-25 05:01AM	Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)
Mar-07-25 11:30AM	Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report? (Zacks)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Mar-04-25 07:37AM	Hologic cut to Hold at Argus amid slower mammography equipment sales (TipRanks)
Feb-26-25 04:01AM	3 Reasons to Sell HOLX and 1 Stock to Buy Instead (StockStory)
Feb-25-25 08:15AM	Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference (Business Wire)
Feb-24-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-21-25 12:28PM	Hologic pockets CE mark for contrast biopsy software (Medical Device Network)
08:30AM	Do Options Traders Know Something About Hologic (HOLX) Stock We Don't? (Zacks)
Feb-20-25 05:23AM	BD business separation could allow competitors to rise in IVD test markets (Medical Device Network)
03:00AM	Hologic Obtains CE Mark for Affirm Contrast Biopsy Software (Business Wire)
Feb-19-25 05:16AM	FDA clears Hologics Aptima SARS-CoV-2 assay (Medical Device Network)
Feb-18-25 08:08AM	Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay (Business Wire)
Feb-12-25 08:08AM	GE HealthCare Earnings: What To Look For From GEHC (StockStory)
Feb-11-25 09:15AM	Deciphering Hologic (HOLX) International Revenue Trends (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:12AM	QuidelOrtho Earnings: What To Look For From QDEL (StockStory)
Feb-07-25 09:40AM	Reddit initiated, Cigna downgraded: Wall Streets top analyst calls (TipRanks)
07:21AM	Why Hologic (HOLX) Stock Went Down On Thursday? (Insider Monkey)
Feb-06-25 09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks) -10.10%
09:34AM	Analyst Report: Hologic, Inc. (Morningstar Research)
08:05AM	Q1 2025 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	Hologic Inc (HOLX) Q1 2025 Earnings Call Highlights: Strong Diagnostics Growth Amid Breast ... (GuruFocus.com)
Feb-05-25 05:30PM	Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Hologic (HOLX) Q1 Earnings Surpass Estimates (Zacks)
04:11PM	Hologic: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:11PM	Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations (StockStory)
04:01PM	Hologic Announces Financial Results for First Quarter of Fiscal 2025 (Business Wire)
Feb-04-25 09:40AM	Hologic (HOLX) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jan-31-25 09:15AM	Countdown to Hologic (HOLX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Jan-29-25 10:01AM	Hologic (HOLX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-28-25 05:45PM	Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-22-25 05:45PM	Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
Jan-21-25 08:00AM	New Report Reveals Alarming Decline in Womens Cancer Testing Worldwide (Business Wire)
Jan-20-25 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Jan-16-25 06:38AM	Hologic receives FDA warning letter over Biozorb implantable markers (MedTech Dive)
Jan-14-25 05:45PM	Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Jan-12-25 04:00PM	Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 (Business Wire)
Jan-08-25 05:45PM	Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Jan-07-25 04:04PM	Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
Jan-06-25 04:15PM	Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 (Business Wire)
08:05AM	Hologic Completes Acquisition of Gynesonics, Inc. (Business Wire)
Jan-03-25 06:46AM	Hologic price target lowered to $76 from $81 at Evercore ISI (TipRanks)
Jan-02-25 05:45PM	Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Dec-26-24 05:45PM	Hologic (HOLX) Flat As Market Sinks: What You Should Know (Zacks)
Dec-24-24 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Dec-23-24 12:19PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Dec-19-24 05:45PM	Here's Why Hologic (HOLX) Fell More Than Broader Market (Zacks)
06:45AM	Hologic agrees with CDC to develop reagents for H5N1 bird flu testing (Medical Device Network)
Dec-18-24 08:08AM	Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC (Business Wire)
Dec-14-24 06:50AM	Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds (TipRanks)
Dec-13-24 07:10PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:45PM	Hologic (HOLX) Stock Moves -1.93%: What You Should Know (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-10-24 11:10PM	Why Is Hologic Inc. (HOLX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
04:01PM	Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines (Business Wire)
Dec-09-24 04:05PM	Martin Madaus Elected to Hologic Board of Directors (Business Wire)
08:05AM	New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence (Business Wire)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Option Exercise	62.60	22,902	1,433,659	52,813	Dec 06 04:28 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Sale	76.34	24,856	1,897,482	27,957	Dec 06 04:28 PM
Mitchell Essex D	Officer	Dec 04 '24	Proposed Sale	76.34	24,856	1,897,484		Dec 04 12:24 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Option Exercise	40.95	32,805	1,343,214	136,721	Sep 03 04:15 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Sale	80.56	52,679	4,243,662	84,042	Sep 03 04:15 PM
Oberton Karleen Marie	Officer	Aug 29 '24	Proposed Sale	80.56	52,679	4,243,657		Aug 29 04:36 PM
Schnittker Brandon	Div. President, GYN Surgical	Aug 06 '24	Sale	83.11	476	39,559	3,735	Aug 08 04:08 PM
Schnittker Brandon	Officer	Aug 06 '24	Proposed Sale	83.11	476	39,559		Aug 06 04:48 PM
COHN BENJAMIN JORDAN	Principal Accounting Officer	Aug 01 '24	Sale	81.99	5,093	417,570	10,476	Aug 05 04:29 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 30 '24	Option Exercise	26.21	44,039	1,154,262	1,201,601	Aug 01 04:09 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 30 '24	Sale	81.70	44,039	3,597,924	1,157,562	Aug 01 04:09 PM
COHN BENJAMIN JORDAN	Officer	Aug 01 '24	Proposed Sale	81.99	5,093	417,574		Aug 01 03:58 PM
MACMILLAN STEPHEN P	Officer	Jul 30 '24	Proposed Sale	81.70	44,039	3,597,894		Jul 30 04:29 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 17 '24	Option Exercise	26.21	3,672	96,243	1,161,234	Jul 19 04:09 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 17 '24	Sale	80.13	3,672	294,223	1,157,562	Jul 19 04:09 PM
Stamoulis Christiana	Director	Jul 17 '24	Option Exercise	26.74	9,039	241,703	54,511	Jul 19 04:06 PM
Stamoulis Christiana	Director	Jul 17 '24	Sale	79.50	9,039	718,600	45,472	Jul 19 04:06 PM

Dollar change -0.94
Percentage change -3.39	%

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI VB VXF VBR SPSM DFAT ROBO IJS SCHA

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	1.77%	Shs Outstand	45.78M	Perf Week	-0.70%
Market Cap	1.22B	Forward P/E	32.14	EPS next Y	0.83	Insider Trans	3.73%	Shs Float	44.88M	Perf Month	-9.59%
Income	-65.36M	PEG	-	EPS next Q	0.13	Inst Own	112.26%	Short Float	10.50%	Perf Quarter	-48.83%
Sales	633.80M	P/S	1.93	EPS this Y	9.06%	Inst Trans	-1.99%	Short Ratio	5.76	Perf Half Y	-42.01%
Book/sh	37.17	P/B	0.72	EPS next Y	86.26%	ROA	-1.70%	Short Interest	4.71M	Perf Year	-51.44%
Cash/sh	7.23	P/C	3.70	EPS next 5Y	38.91%	ROE	-2.00%	52W Range	23.91 - 63.58	Perf YTD	-46.46%
Dividend Est.	-	P/FCF	47.23	EPS past 5Y	-	ROI	-3.72%	52W High	-57.90%	Beta	1.64
Dividend TTM	-	Quick Ratio	2.84	Sales past 5Y	1.70%	Gross Margin	40.31%	52W Low	11.96%	ATR (14)	1.76
Dividend Ex-Date	Dec 02, 2021	Current Ratio	3.22	EPS Y/Y TTM	48.51%	Oper. Margin	-6.97%	RSI (14)	43.20	Volatility	6.82% 5.84%
Employees	3300	Debt/Eq	0.03	Sales Y/Y TTM	-2.76%	Profit Margin	-10.31%	Recom	3.00	Target Price	32.80
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	64.17%	Payout	-	Rel Volume	1.07	Prev Close	27.71
Sales Surprise	1.80%	EPS Surprise	-28.57%	Sales Q/Q	-9.88%	Earnings	May 07 BMO	Avg Volume	818.78K	Price	26.77
SMA20	1.93%	SMA50	-17.22%	SMA200	-39.94%	Trades		Volume	878,074	Change	-3.39%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
09:01AM	Loading…
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
04:05PM	Loading…
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
04:05PM	Loading…
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:06PM	Azenta Announces CEO Succession Plan (PR Newswire)
04:05PM	Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 (PR Newswire)
May-01-24 04:05PM	Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-01-24 04:15PM	Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report (PR Newswire)
04:05PM	Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-12-24 08:00AM	Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum (PR Newswire)
Feb-08-24 10:53AM	Azenta, Inc. (NASDAQ:AZTA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-07-24 05:02PM	Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024 (GuruFocus.com)
04:05PM	Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 (PR Newswire)
Feb-02-24 08:00AM	Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management (PR Newswire)
Jan-25-24 04:05PM	Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-11-24 04:05PM	Azenta to Host Investor Day on March 14, 2024 (PR Newswire)
Jan-09-24 04:05PM	Azenta to Participate in the 26th Annual Needham Growth Conference (PR Newswire)
Jan-03-24 04:05PM	Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Nov-21-23 04:05PM	Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-23 01:06PM	Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.89%
Nov-13-23 05:04PM	Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure (GuruFocus.com)
04:07PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023 (PR Newswire)
04:06PM	Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation (PR Newswire)
04:05PM	Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project (PR Newswire)
Nov-10-23 04:05PM	Azenta to Participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-23 04:05PM	Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)
Oct-19-23 04:05PM	Azenta to Host GENEWIZ Week November 6-10, 2023 (PR Newswire)
Sep-26-23 08:00AM	Azenta Announces CFO Transition (PR Newswire)
Sep-08-23 04:05PM	Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
Sep-07-23 04:05PM	Azenta to Participate in the Baird 2023 Global Healthcare Conference (PR Newswire)
Aug-10-23 08:00AM	Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 (PR Newswire)
Aug-09-23 04:05PM	Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference (PR Newswire) +20.33%
12:00PM	Azenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70% (Simply Wall St.)
Aug-08-23 04:05PM	Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023 (PR Newswire)
Aug-03-23 04:05PM	Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jun-29-23 04:05PM	Azenta Announces New Biorepository in the Greater Boston Area (PR Newswire)
Jun-21-23 08:00PM	AZTA: Lowering target price to $36.00 (Argus Research)
May-31-23 10:24AM	Vazyme Signs Global Strategic Cooperation Agreement with Azenta (PR Newswire)
May-30-23 04:05PM	Azenta to Participate in the Jefferies Healthcare Conference (PR Newswire)
May-24-23 08:00AM	Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery (PR Newswire)
May-17-23 04:05PM	Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference (PR Newswire) +5.53%
May-09-23 04:05PM	Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment (PR Newswire) -18.89%
May-03-23 04:05PM	Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-26-23 08:00PM	AZTA: Lowering target price to $43.00 (Argus Research)
Apr-13-23 07:00PM	Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-15-23 05:06PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (PR Newswire)
Mar-07-23 04:15PM	Azenta Publishes its Environmental, Social, & Governance (ESG) Report (PR Newswire)
Feb-28-23 04:05PM	Azenta to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-27-23 07:30AM	Azenta Launches Cryo Store Pico, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications (PR Newswire)
Feb-10-23 07:30AM	Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (PR Newswire)
Feb-08-23 04:05PM	Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022 (PR Newswire) -18.29%
Feb-06-23 04:35PM	Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Feb-03-23 07:00AM	Azenta Announces the Acquisition of Ziath (PR Newswire)
Jan-23-23 09:00AM	Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors (GlobeNewswire)
Jan-05-23 08:00AM	Azenta to participate in the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
07:55AM	Azenta to participate in the 25th Annual Needham Growth Conference (PR Newswire)
Dec-22-22 11:21AM	Should You Consider Azenta (AZTA) for Investment? (Insider Monkey)
Nov-23-22 07:15AM	Azenta Announces $500 Million Accelerated Share Repurchase Agreement (PR Newswire)
Nov-21-22 04:05PM	Azenta to participate in the 5th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-22 04:10PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program (PR Newswire) +21.83%
04:09PM	Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors (PR Newswire)
Nov-09-22 08:30AM	Azenta to participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-22 04:52PM	Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg (PR Newswire)
Nov-07-22 04:38PM	Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hughes Violetta	VP, Chief Accounting Officer	Feb 03 '25	Sale	52.97	317	16,791	9,603	Feb 04 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Jan 31 '25	Buy	45.88	417	19,132	27,916	Feb 04 04:10 PM
Pirogova Olga	SVP and CHRO	Nov 19 '24	Sale	40.07	548	21,958	19,373	Nov 21 04:10 PM
Hughes Violetta	VP, Chief Accounting Officer	Nov 19 '24	Sale	40.07	163	6,531	9,920	Nov 21 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Nov 19 '24	Sale	40.07	491	19,674	27,499	Nov 21 04:10 PM
Wang David Dong	SVP & GM, SMS	Nov 19 '24	Sale	40.07	348	13,944	24,114	Nov 21 04:10 PM
Joseph Jason	SVP, General Counsel, Secy.	Nov 19 '24	Sale	40.07	1,139	45,640	112,564	Nov 21 04:10 PM
Cueto Herman	EVP, Chief Financial Officer	Nov 19 '24	Sale	40.07	712	28,530	23,892	Nov 21 04:10 PM
Marotta John	President and CEO	Nov 18 '24	Buy	39.48	12,717	502,066	99,612	Nov 19 04:10 PM
Marotta John	President and CEO	Nov 19 '24	Buy	40.67	1,250	50,838	100,862	Nov 19 04:10 PM
Cornog William L	Director	Nov 18 '24	Buy	39.60	12,500	495,000	14,755	Nov 19 04:10 PM
HIRSCH DIDIER	Director	Nov 18 '24	Buy	39.50	1,000	39,500	3,465	Nov 19 04:10 PM
Madaus Martin D	Director	Nov 19 '24	Buy	40.77	4,940	201,404	7,405	Nov 19 04:00 PM
Cueto Herman	EVP, Chief Financial Officer	Oct 17 '24	Sale	43.68	1,595	69,670	24,604	Oct 21 04:10 PM
JASON JOSEPH	Officer	Aug 01 '24	Proposed Sale	62.05	1,000	62,050		Aug 01 04:26 PM

Dollar change -4.61
Percentage change -3.61	%

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: IJH VTI VB VXF VBK MDY IBB FBT SPMD IWR

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	5.47%	Shs Outstand	56.18M	Perf Week	-12.91%
Market Cap	6.92B	Forward P/E	56.67	EPS next Y	2.17	Insider Trans	-1.62%	Shs Float	53.11M	Perf Month	-0.49%
Income	-22.98M	PEG	-	EPS next Q	0.40	Inst Own	100.92%	Short Float	6.10%	Perf Quarter	-21.03%
Sales	650.43M	P/S	10.65	EPS this Y	6.06%	Inst Trans	-1.45%	Short Ratio	3.89	Perf Half Y	-15.56%
Book/sh	35.34	P/B	3.49	EPS next Y	29.79%	ROA	-0.81%	Short Interest	3.24M	Perf Year	-26.52%
Cash/sh	12.41	P/C	9.93	EPS next 5Y	20.59%	ROE	-1.16%	52W Range	102.96 - 182.52	Perf YTD	-14.38%
Dividend Est.	-	P/FCF	57.83	EPS past 5Y	-	ROI	-0.87%	52W High	-32.48%	Beta	1.19
Dividend TTM	-	Quick Ratio	5.79	Sales past 5Y	23.47%	Gross Margin	46.39%	52W Low	19.69%	ATR (14)	8.06
Dividend Ex-Date	-	Current Ratio	6.79	EPS Y/Y TTM	-196.93%	Oper. Margin	4.15%	RSI (14)	39.31	Volatility	5.64% 5.66%
Employees	1778	Debt/Eq	0.34	Sales Y/Y TTM	4.88%	Profit Margin	-3.53%	Recom	1.55	Target Price	184.00
Option/Short	Yes / Yes	LT Debt/Eq	0.34	EPS Q/Q	76.84%	Payout	-	Rel Volume	0.70	Prev Close	127.85
Sales Surprise	3.35%	EPS Surprise	12.68%	Sales Q/Q	10.44%	Earnings	Apr 29 BMO	Avg Volume	832.92K	Price	123.24
SMA20	-8.37%	SMA50	-10.15%	SMA200	-15.69%	Trades		Volume	580,989	Change	-3.61%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$143 → $151
May-07-20	Reiterated	H.C. Wainwright	Buy	$100 → $143

Show Previous Ratings

May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
04:19PM	Loading…
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
07:08PM	Loading…
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
05:01AM	Loading…
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)
Mar-11-25 05:01AM	A Look Back at Drug Development Inputs & Services Stocks Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack (StockStory) +7.40%
Mar-10-25 08:06PM	Analyst Report: Repligen Corporation (Morningstar Research) -12.02%
Mar-06-25 08:02AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Feb-21-25 04:28PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:06AM	Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:24AM	Q4 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-20-25 07:21PM	Analyst Report: Repligen Corporation (Morningstar Research) +7.92%
02:00PM	Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook (Benzinga)
08:54AM	What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings (GuruFocus.com)
08:45AM	Repligen (RGEN) Beats Q4 Earnings Estimates (Zacks)
08:08AM	Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates (StockStory)
07:50AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-19-25 08:05AM	Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow (StockStory)
Feb-12-25 08:44PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:17AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-11-25 07:30AM	Repligen to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-29-25 03:19AM	Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains? (Zacks)
Jan-13-25 07:18PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-07-25 07:30AM	Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-06-25 07:30AM	Repligen Launches the CTech SoloVPE PLUS System (GlobeNewswire)
Dec-20-24 09:21AM	Repligen Corporation (RGEN) Fell Along with Peers (Insider Monkey)
Dec-18-24 09:40PM	Analyst Report: Repligen Corporation (Morningstar Research) -6.83%
Dec-16-24 07:43PM	Analyst Report: Repligen Corporation (Morningstar Research)
08:11AM	BioLife Solutions Appoints Tony J. Hunt to its Board of Directors (PR Newswire)
Dec-12-24 11:30AM	Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? (Zacks)
07:30AM	Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report (GlobeNewswire)
Dec-09-24 09:03AM	Several Factors Lifted Repligen Corporation (RGEN) in Q3 (Insider Monkey)
07:30AM	Repligen Launches Novel AVIPure dsRNA Resin in OPUS Pre-packed Columns (GlobeNewswire)
Nov-13-24 09:54AM	Analyst Report: Repligen Corporation (Morningstar Research)
02:37AM	Q3 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
02:08AM	Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-24 11:55AM	Repligen Stock Soars 10% on Record Growth and Bold Moves (GuruFocus.com) +6.51%
09:05AM	Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:04AM	Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 07:30AM	Repligen to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 10:01AM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)
Oct-04-24 11:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Oct-03-24 11:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
Sep-24-24 07:30AM	Repligen Opens Training & Innovation Center to Elevate Customer Experience (GlobeNewswire)
Sep-11-24 06:35AM	Several Headwinds Dragged Repligen Corporation (RGEN) in Q2 (Insider Monkey)
Sep-09-24 05:20AM	Reasons for the Decline of Repligen (RGEN) in Q2 (Insider Monkey)
Sep-07-24 07:37AM	Repligen Corporation (RGEN) Fell Due to CEO Transition (Insider Monkey)
Aug-29-24 11:31AM	Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-23-24 08:43AM	Repligen Corporation (RGEN) Benefitted From Drug Approval (Insider Monkey)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-16-24 04:39AM	Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? (Insider Monkey) -9.26%
Aug-02-24 07:09AM	Here's Why Shares in This Hot Healthcare Stock Surged This Week (Motley Fool)
Jul-31-24 10:46AM	Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates (Zacks)
12:30AM	Q2 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 08:45AM	Repligen (RGEN) Q2 Earnings Meet Estimates (Zacks) +16.37%
07:45AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2024 Financial Results (GlobeNewswire)
02:55AM	Should You Consider Investing in Repligen Corporation (RGEN)? (Insider Monkey)
Jul-29-24 04:00PM	Repligen Announces Agreement to Acquire Chromatography Innovator Tantti (GlobeNewswire)
Jul-23-24 10:01AM	Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-20-24 08:21AM	Repligen Corporation (RGEN): Why Are Hedge Funds Bullish On This Profitable Stock Right Now? (Insider Monkey)
Jul-16-24 07:30AM	Repligen to Report Second Quarter 2024 Financial Results (GlobeNewswire) +10.11%
Jun-24-24 07:33AM	Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock? (Zacks)
Jun-15-24 02:50AM	Insider Buying: CEO Anthony Hunt Acquires Shares of Repligen Corp (RGEN) (GuruFocus.com)
02:50AM	Director Nicolas Barthelemy Acquires 1,200 Shares of Repligen Corp (RGEN) (GuruFocus.com)
Jun-14-24 11:43AM	Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change (Zacks)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM
Hunt Anthony	Director	Dec 05 '24	Option Exercise	33.87	11,808	399,937	151,648	Dec 05 08:26 PM
Hunt Anthony	Director	Nov 21 '24	Option Exercise	33.87	24,246	821,212	164,086	Nov 22 04:52 PM
Hunt Anthony	Director	Nov 21 '24	Sale	139.67	24,246	3,386,439	139,840	Nov 22 04:52 PM
Anthony Hunt	Executive Chairman	Nov 21 '24	Proposed Sale	139.66	24,246	3,386,311		Nov 21 03:52 PM
MUIR GLENN P	Director	Nov 19 '24	Option Exercise	36.29	19,000	689,510	32,283	Nov 20 02:29 PM
Hunt Anthony	Director	Sep 10 '24	Option Exercise	33.87	10,000	338,700	162,031	Sep 12 11:35 AM
Hunt Anthony	Director	Sep 10 '24	Sale	145.37	22,191	3,225,927	139,840	Sep 12 11:35 AM
Hunt Anthony	Officer	Sep 10 '24	Proposed Sale	144.72	22,191	3,211,481		Sep 10 04:03 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Option Exercise	86.10	175	15,067	12,463	Aug 05 09:56 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Sale	159.35	7,148	1,139,016	12,288	Aug 05 09:56 PM
Ralf Kuriyel	Senior Vice President	Aug 02 '24	Proposed Sale	159.35	7,148	1,139,040		Aug 02 03:26 PM
KURIYEL RALF	Senior VP, R&D	Aug 01 '24	Sale	165.67	4,465	739,717	19,261	Aug 01 08:47 PM
MUIR GLENN P	Director	Aug 01 '24	Option Exercise	36.29	5,000	181,450	13,283	Aug 01 05:04 PM
Christine Gebski	Senior Vice President	Aug 01 '24	Proposed Sale	167.00	2,160	360,720		Aug 01 04:11 PM
Ralf Kuriyel	Senior Vice President	Aug 01 '24	Proposed Sale	165.67	4,465	739,705		Aug 01 04:07 PM
Madaus Martin D	Director	Jun 14 '24	Buy	124.94	1,615	201,776	4,613	Jun 14 06:07 PM
BARTHELEMY NICOLAS	Director	Jun 14 '24	Buy	125.45	1,200	150,540	4,668	Jun 14 05:42 PM
Hunt Anthony	Chief Executive Officer	Jun 14 '24	Buy	124.08	2,000	248,160	165,177	Jun 14 05:41 PM
DAWES KAREN A	Director	Jun 14 '24	Option Exercise	67.71	2,953	199,948	88,170	Jun 14 05:33 PM
Hunt Anthony	Chief Executive Officer	May 21 '24	Sale	168.26	20,072	3,377,283	163,177	May 22 05:14 PM

HOLX

Hologic, Inc

AZTA

Azenta Inc

RGEN

Repligen Corp

Upgrade your FINVIZ experience